3-Dehydromitragynine; (2S,3S)-2((E)-1,3-Dimethoxy-3-oxoprop-1-en-2-yl)-3-ethyl-8-methoxy-2,3,4,6,7,12-hexahydro-1H-indolo[2,3-a]quinolizine-5-ium

ID: ALA5276728

Chembl Id: CHEMBL5276728

Max Phase: Preclinical

Molecular Formula: C23H29N2O4+

Molecular Weight: 397.50

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@H]1C[N+]2=C(C[C@@H]1/C(=C\OC)C(=O)OC)c1[nH]c3cccc(OC)c3c1CC2

Standard InChI:  InChI=1S/C23H28N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16H,5,9-12H2,1-4H3/p+1/b17-13+/t14-,16+/m1/s1

Standard InChI Key:  LRKSTCBIGUUOED-DCHMLSIZSA-O

Alternative Forms

  1. Parent:

    ALA5276728

    ---

Associated Targets(non-human)

Oprm1 Mu opioid receptor (1674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprk1 Kappa opioid receptor (991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprd1 Delta opioid receptor (3127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.50Molecular Weight (Monoisotopic): 397.2122AlogP: 3.28#Rotatable Bonds: 5
Polar Surface Area: 63.56Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.84CX Basic pKa: CX LogP: -0.60CX LogD: -0.60
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.36Np Likeness Score: 1.32

References

1. Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, Wilson LL, Scouller B, Alder AF, Kruegel AC, Ansonoff M, Varadi A, Eans SO, Hunkele A, Allaoa A, Kalra S, Xu J, Pan YX, Pintar J, Kivell BM, Pasternak GW, Cameron MD, McLaughlin JP, Sames D, Majumdar S..  (2021)  Oxidative Metabolism as a Modulator of Kratom's Biological Actions.,  64  (22.0): [PMID:34783240] [10.1021/acs.jmedchem.1c01111]

Source